PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 50 filers reported holding PROQR THRAPEUTICS N V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,032 | -85.0% | 57,717 | -81.3% | 0.00% | -100.0% |
| Q2 2023 | $501,323 | -62.5% | 309,459 | -50.6% | 0.00% | -66.7% |
| Q1 2023 | $1,335,352 | -14.2% | 626,926 | +49.0% | 0.00% | -25.0% |
| Q4 2022 | $1,556,275 | +2729.6% | 420,615 | +472.8% | 0.00% | – |
| Q3 2022 | $55,000 | -58.6% | 73,430 | -57.1% | 0.00% | – |
| Q2 2022 | $133,000 | -93.7% | 171,172 | -46.1% | 0.00% | -100.0% |
| Q1 2021 | $2,100,000 | +122.2% | 317,705 | +389.6% | 0.01% | -16.7% |
| Q3 2015 | $945,000 | -12.7% | 64,886 | 0.0% | 0.01% | -14.3% |
| Q2 2015 | $1,082,000 | -23.8% | 64,886 | 0.0% | 0.01% | -26.3% |
| Q1 2015 | $1,420,000 | +12.2% | 64,886 | +11.1% | 0.02% | +11.8% |
| Q4 2014 | $1,266,000 | -35.2% | 58,417 | -48.6% | 0.02% | -39.3% |
| Q3 2014 | $1,954,000 | – | 113,676 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |